MSB 1.84% 96.8¢ mesoblast limited

Ann: P3 Trial of MSB's Cell Therapy in CHF Completes Recruitment, page-20

  1. 693 Posts.
    lightbulb Created with Sketch. 266
    Don't forget folks that we're only halfway there - remember the agreement we made with FDA that requires us to conduct another 600 patient Phase 3 trial ...
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.